name: ZINC OXIDE 21.2 g in 80 mL TOPICAL CREAM [Sunscreen for kids SPF50]


name: GLYCERIN 4.5 mg in 30 mg / STEVIA REBAUDIANA WHOLE 3 mg in 30 mg / HYDROLYZED PORCINE COLLAGEN (ENZYMATIC; 3000 MW) 4.5 mg in 30 mg / BIOTIN 6 mg in 30 mg TOPICAL OIL [Biotin With Hydrolyzed Collagen Oil]


name: GLYCERIN 5 mg in 50 g / BUTYLENE GLYCOL 3 mg in 50 g CUTANEOUS CREAM


name: GLYCERIN 5 mg in 60 mL / HYALURONIC ACID 3 mg in 60 mL CUTANEOUS CREAM


name: EUCALYPTUS OIL 0.15 g in 1 g / MENTHOL, UNSPECIFIED FORM 0.2 g in 1 g / ARGININE 0.1 g in 1 g TOPICAL CREAM [Slimming Detox Nasal Cannula]


name: HAMAMELIS VIRGINIANA TOP 3 g in 30 g / HYALURONIC ACID 7.5 g in 30 g / MENTHA PIPERITA LEAF 4.5 g in 30 g TOPICAL STRIP [Nose Plants Pores Strips]


name: MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL 0.0007 g in 30 mL / 3-O-ETHYL ASCORBIC ACID 0.03 g in 30 mL CUTANEOUS SOLUTION, GEL FORMING / DROPS [YOUBUY TEA TREE ACNE ESSENCE]


name: NIACINAMIDE 0.01 g in 20 g / NIACIN 0.12 g in 20 g CUTANEOUS CREAM [BARUBT BRIGHTENING]


name: NIACINAMIDE 1 g in 1 mg / RESVERATROL 1 g in 1 mg AURICULAR (OTIC) EMULSION [Niacinamide Brightening Facial Cleanser]


name: ROSE OIL 30 g in 30 mL TOPICAL OIL [Pressed Rose Hip Seed Oil]


name: TRANEXAMIC ACID 0.45 g in 15 g / ALPHA-ARBUTIN 0.3 g in 15 g CUTANEOUS CREAM [BARUBT Melasma spotless concentrate cream]


name: WORMWOOD 0.5 g TOPICAL PATCH [Wormwood belly button patch]


name: ZINC OXIDE 0.57 g in 15 mL TOPICAL CREAM [S.O.S Cream Intensive Moisturizing Skin Protectant]


name: ZINC OXIDE 1.55 g in 80 mL TOPICAL CREAM [AfterSun]


name: ALLANTOIN 5 mg in 1 g TOPICAL GEL [Manuka Honey Extra Strength]


name: ALUMINUM CHLOROHYDRATE 4.4 g in 1 mg AURICULAR (OTIC) EMULSION [Antiperspirant]


name: OCTOCRYLENE 90 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL OIL [Bali Body Pineapple Tanning Oil SPF15]


name: GLYCERIN 5 mg in 100 mL / KOJIC ACID 3 mg in 100 mL CUTANEOUS LIQUID


name: HOUTTUYNIA CORDATA TOP 5 g in 150 g / JOJOBA OIL 5 g in 150 g / TOCOPHEROL 5 g in 150 g TOPICAL OIL [Cleansing]


name: HYALURONIC ACID 5 g in 30 mL TOPICAL LOTION


name: TOCOPHEROL 5 g in 150 g / COCONUT OIL 5 g in 150 g TOPICAL OIL [DRUGGIST Nuorishing cleansing]


name: TOCOPHEROL 5 g in 150 g / JOJOBA OIL 5 g in 150 g / HOUTTUYNIA CORDATA TOP 5 g in 150 g TOPICAL OIL [HEARTLEAF PORE CONTROL CLEANSING]


name: ALUMINUM CHLORIDE 4.35 mg in 30 mL TOPICAL SPRAY [Antiperspirant ODABAN]


name: BUTYLENE GLYCOL 1.6 mg in 100 mL TOPICAL SHAMPOO [Srripo Biotin Hair Treatment]


name: CAMPHOR, (-)- 0.1 g in 45 mL TOPICAL LIQUID [Anti Acne Serum]


name: CAMPHOR, (-)- 1 g in 24 g TOPICAL PATCH [Acne Patch]


name: CASTOR OIL 100 g in 100 mL TOPICAL OIL [Anyi Beauty Biotin With Collagen Peptides Oil]


name: DIMETHICONE 30 mg in 1 mL TOPICAL CREAM [AnYi Beauty Dark Spot Corrector Cream]


name: PROPANEDIOL 0.1 mg in 100 mL TOPICAL SHAMPOO [Srripo Biotin Shampoo/]


name: OCTINOXATE 6 mg in 1 mL TOPICAL CREAM [Note Mattifying Extreme Wear Foundation 02 Natural Beige]


name: OCTOCRYLENE 90 mg in 1 mL / HOMOSALATE 73 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [ANUA HEARTLEAF SILKY MOISTURE MILD SUNSCREEN]


name: COCAMIDOPROPYL BETAINE 5 mg in 300 mL / DIPROPYLENE GLYCOL 3 mg in 300 mL CUTANEOUS SHAMPOO [Batana Oil HairGrowthShampoo]


name: NIACINAMIDE 2 g in 30 mL / ASCORBYL GLUCOSIDE 7 g in 30 mL / TOCOPHEROL 3 g in 30 mL TOPICAL LIQUID [FACIAL SERUM]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Bloomeffects Tulipscreen Hydrating Lip Oil]


name: ZINC OXIDE 39.2 mg in 1 g / OCTINOXATE 25 mg in 1 g TOPICAL STICK [CYZONE CY PLAY CREAMY LIP BALM HIDRATANTE EN BARRA PARA LABIOS 24H FPS 12 BERRY CREAMY]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [sunscreen]


name: TITANIUM DIOXIDE 4.95 g in 100 g / ZINC OXIDE 9.5 g in 100 g TOPICAL LOTION [Natural Mineral Sunscreen]


name: HOMOSALATE 4.5 g in 50 mL / OCTISALATE 2.25 g in 50 mL / AVOBENZONE 1.35 g in 50 mL TOPICAL CREAM [THANK YOU FARMER Sun Project Soothing]


name: OCTISALATE 2.25 g in 50 mL / OCTINOXATE 3.4 g in 50 mL / OCTOCRYLENE 2 g in 50 mL / AVOBENZONE 1.35 g in 50 mL / HOMOSALATE 4.5 g in 50 mL TOPICAL CREAM [Sun Project Moisture]


name: ALUMINUM CHLOROHYDRATE 1.4 g in 35 mL / HAMAMELIS VIRGINIANA WHOLE 0.01225 g in 35 mL / HYDROXYACETOPHENONE 0.00175 g in 35 mL CUTANEOUS SPRAY [BARUBT Gluta Deodorant Spary]


name: TECHNETIUM TC-99M SULFUR COLLOID 10 mCi in 10 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [Kit for the Prepartion of Technetium Tc99m Sulfur Colloid]


name: ZINC OXIDE 11.12 g in 50 mL TOPICAL CREAM [THANK YOU FARMER Sun Project Rice Tinted Mineral Sun Cream]


name: ZINC OXIDE 132 mg in 1 mL TOPICAL LOTION [Ciele Bronze and Protect]


name: ZINC OXIDE 165 mg in 1 g TOPICAL STICK [Ciele Sculpt and Protect]


name: ZINC OXIDE 17.5 g in 100 g TOPICAL CREAM [OS-01 Face SPF BS SPF30 Tinted]


name: CASTOR OIL 5 g in 30 mL TOPICAL OIL [Castor]


name: GLYCOLIC ACID 7 mg in 100 mL CUTANEOUS LIQUID


name: MALTOOLIGOSYL GLUCOSIDE 0.27 g in 55 g / HYDROGENATED STARCH HYDROLYSATE 0.165 g in 55 g CUTANEOUS CREAM [BARUBT NOSE PLANTS PORE STRIPS]


name: MINERAL OIL 1.2 g in 20 g / ACETYL HEXAPEPTIDE-8 0.0001 g in 20 g / ETHYLHEXYL PALMITATE 0.8 g in 20 g / CENTELLA ASIATICA LEAF 0.007 g in 20 g CUTANEOUS CREAM [YOUBUY Anti Wrinkle Cream]


name: PANTHENOL 0.0175 g in 35 mL / LACTIC ACID 0.175 g in 35 mL / GLYCOLIC ACID 0.175 g in 35 mL CUTANEOUS LOTION [BARUBT Intensive Peeling Solution]


name: PANTHENOL 0.5 g in 100 g / ASCORBIC ACID 0.2 g in 100 g CUTANEOUS CREAM [BARUBT TEMPORARY FACE TIGHTENER]


name: PEG-20 METHYL GLUCOSE SESQUISTEARATE 3 mg in 50 mL / CAPRYLIC/CAPRIC/LAURIC TRIGLYCERIDE 5 mg in 50 mL CUTANEOUS CREAM


name: PRUNELLA VULGARIS 2 g in 40 g / NIACINAMIDE 0.8 g in 40 g / ARTEMISIA PRINCEPS WHOLE 2 g in 40 g / HOUTTUYNIA CORDATA WHOLE 2 g in 40 g / CENTELLA ASIATICA 21.404 g in 40 g CUTANEOUS CREAM [BARUBT All day Shield Cream]


name: RICE GERM 39000 mg in 130 g / CERAMIDE AP 2600 mg in 130 g / COLLAGEN, SOLUBLE, FISH SKIN 2600 mg in 130 g / TOCOPHEROL 1300 mg in 130 g / HYALURONIC ACID 1300 mg in 130 g TOPICAL CREAM [AOAO Rice Ceramide Anti Wrinkle Cream]


name: CAMPHOR, (-)- 0.1 g in 45 mL TOPICAL LIQUID [Anti Aging Serum]


name: ALLANTOIN 0.06 g in 40 mL / PANTHENOL 0.044 g in 40 mL / NIACINAMIDE 2 g in 40 mL / SALICYLIC ACID 0.4 g in 40 mL CUTANEOUS LOTION [BARUBY SALICYLIC ACID ACNE DRYING]


name: AVENA SATIVA WHOLE 0.003 g in 30 mL / NIACINAMIDE 3 g in 30 mL / HYALURONIC ACID 0.015 g in 30 mL CUTANEOUS LOTION [BARUBT Niacinamide Hyaluronic Acid Serum]


name: BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES 1.2 g in 40 g / DICAPRYLYL ETHER 0.8 g in 40 g / NIACINAMIDE 0.4 g in 40 g CUTANEOUS CREAM [BARUBT Night Renewal Cream]


name: ASCORBIC ACID 2 g in 50 mL TOPICAL LIQUID [FACIAL SERUM]


name: ASCORBYL GLUCOSIDE 0.1 g in 20 g / NIACIN 0.04 g in 20 g CUTANEOUS CREAM [YOUBUY Whitening and Freckle Removing Cream]


name: ALLANTOIN 1.5 g in 100 g TOPICAL CREAM [BioBarrier Repair Eye Cream]


name: OCTINOXATE 6 mg in 1 mL TOPICAL CREAM [Note BB 100 Porcelain]


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Crystal Clear Flawless Clear Clean]


name: CAPSAICIN 0.25 g in 100 g TOPICAL CLOTH [Nufabrx Medicine Infused Wrist Sleeve]


name: GLYCERIN 2 g in 50 mL TOPICAL CREAM [DARK SPOT]


name: HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Cancer Council Protect and Hydrate Radiance SPF50 Plus]


name: OCTISALATE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Cancer Council Daily Body Moisturizer SPF50 Plus]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL PASTE [GLC OG Natural Tinted SPF 30 Sunscreen]


name: TOCOPHEROL 2 mg in 70 a TOPICAL CAPSULE [Skin Care and Hair Care Set]


name: TITANIUM DIOXIDE 0.0032 g in 40 g / TARAXACUM MONGOLICUM 0.01 g in 40 g / SCUTELLARIA BAICALENSIS ROOT 0.016 g in 40 g / GLYCYRRHIZA GLABRA 0.014 g in 40 g / LONICERA JAPONICA FLOWER 0.014 g in 40 g / SOPHORA FLAVESCENS ROOT 0.016 g in 40 g CUTANEOUS PASTE [BARUBT Alaska Volcano Pore Clay Stick]


name: HOMOSALATE 13.5 g in 100 mL / OCTISALATE 4.5 g in 100 mL / AVOBENZONE 2.7 g in 100 mL TOPICAL CREAM [ROUND LAB BIRCH JUICE MOISTURIZING UVLOCK SUNSCREEN SPF45 BROAD SPECTRUM]


name: OCTOCRYLENE 1 g in 50 g / ZINC OXIDE 2.5 g in 50 g / TITANIUM DIOXIDE 1 g in 50 g TOPICAL CREAM


name: ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY 16 g in 100 g TOPICAL GEL [Secret Brown Sugar Clear]


name: ZINC OXIDE 1.182 mg in 30 mL / TITANIUM DIOXIDE 1.734 mg in 30 mL / OCTOCRYLENE 0.9 mg in 30 mL TOPICAL CREAM


name: ZINC OXIDE 10 g in 100 mL / TITANIUM DIOXIDE 6 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION [APPTI Body Sunscreen]


name: ZINC OXIDE 5 g in 100 mL / TITANIUM DIOXIDE 6 g in 100 mL / OCTOCRYLENE 4 g in 100 mL TOPICAL LOTION [APPTI Face Sunscreen]


name: ZINC OXIDE 5 g in 30 mL / TITANIUM DIOXIDE 5 g in 30 mL TOPICAL CREAM [YOUNG CLARITI BY BIO UTH Mineral Brightening Sheer Tint BROAD SPECTRUM SPF 20]


name: ZINC OXIDE 9.6 g in 50 mL / TITANIUM DIOXIDE 1.56 g in 50 mL TOPICAL CREAM [TIBENA EVERY DAY REAL SUN BLOCK]


name: CENTELLA ASIATICA LEAF 0.014 g in 40 g / NIACINAMIDE 0.4 g in 40 g / GLYCYRRHIZA URALENSIS 0.014 g in 40 g / GLYCOLIC ACID 0.02 g in 40 g CUTANEOUS PASTE [BARUBT Ocean Pore Clay Stick]


name: COLLAGEN, SOLUBLE, FISH SKIN 1000 mg in 50 mL / TOCOPHEROL 500 mg in 50 mL / GARDEN SNAIL MUCIN 12500 mg in 50 mL / ASCORBIC ACID 500 mg in 50 mL / FERMENT COMPLEX 6/PF 15000 mg in 50 mL / ASIAN GINSENG 1000 mg in 50 mL TOPICAL LIQUID [AOAO Snail Ginseng Anti Wrinkle Serum]


name: DIPROPYLENE GLYCOL 3 mg in 300 mL / COCAMIDOPROPYL BETAINE 5 mg in 300 mL CUTANEOUS SHAMPOO [Batana OilShampoo]


name: ETHYLHEXYL TRIAZONE 1.5 mg in 50 mL / DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE 2.5 mg in 50 mL TOPICAL ELIXIR [Pfect A solar barrier Serum Textured]


name: MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL 0.3 g in 150 g / SALICYLIC ACID 3 g in 150 g / UREA 60 g in 150 g CUTANEOUS CREAM [BARUBT Urea Cream]


name: MINERAL OIL 16.732 g in 40 g / TOCOPHEROL 0.4 g in 40 g CUTANEOUS CREAM [BARUBT Peach Moisturizing Cream]


name: NIACINAMIDE 2 mg in 100 mL / GOLD 2 mg in 100 mL / PANAX GINSENG ROOT WATER 2 mg in 100 mL CUTANEOUS LIQUID


name: NIACINAMIDE 3 g in 50 g / ARBUTIN 2.5 g in 50 g / ASCORBIC ACID 3 g in 50 g TOPICAL CREAM [DARK SPOT CORRECTOR]


name: SODIUM LAURYL SULFATE 0.39 g in 15 g / ETHYLHEXYLGLYCERIN 0.003 g in 15 g ORAL POWDER [YOUBUY Teeth whitening powder]


name: SQUALANE 1 g in 100 mg EXTRACORPOREAL CREAM [MlELLERosemaryMintShampooConditionerHairMaskOil]


name: GARDEN SNAIL MUCIN 58500 mg in 130 g / ASIAN GINSENG 2600 mg in 130 g / COLLAGEN, SOLUBLE, FISH SKIN 2600 mg in 130 g / TOCOPHEROL 1300 mg in 130 g / ASCORBIC ACID 1300 mg in 130 g TOPICAL CREAM [AOA0 Snail Ginseng Cream]


name: GLYCERIN 2 g in 50 mL TOPICAL CREAM [DARK SPOT CORRECTOR Cream]


name: GLYCOLIC ACID 0.02 g in 40 g / SALICYLIC ACID 0.04 g in 40 g / STRAWBERRY 0.02 g in 40 g / RASPBERRYKETONE GLUCOSIDE 0.02 g in 40 g / NIACINAMIDE 0.08 g in 40 g CUTANEOUS PASTE [BARUBT Strawberry Pore Clay Stick]


name: HYALURONIC ACID 6 mg in 30 mg / JOJOBA OIL 3 mg in 30 mg / ASCORBIC ACID 4.5 mg in 30 mg TOPICAL LIQUID [Instant Tighten Lift Essence]


name: HYDROXYACETOPHENONE 0.00025 g in 50 g / CITRUS JUNOS FRUIT 0.05 g in 50 g / AVENA SATIVA WHOLE 0.0005 g in 50 g CUTANEOUS GEL [BARUBT Orange Exfoliating Whitening Gel]


name: OATMEAL 1 mg in 100 g TOPICAL GEL [Whipped Gel]


name: OENOCARPUS BATAUA SEED OIL 100 g in 100 g TOPICAL CAPSULE [GZE Batana Hair oil]


name: PHENOXYETHANOL 5 mg in 30 mL / ASCORBIC ACID 3 mg in 30 mL CUTANEOUS LIQUID


name: POLYGONUM CUSPIDATUM LEAF 0.05 g in 50 g / CENTELLA ASIATICA LEAF 0.05 g in 50 g / RETINOL 0.05 g in 50 g / CERAMIDE NP 0.05 g in 50 g / ROSMARINUS OFFICINALIS FLOWER 0.05 g in 50 g CUTANEOUS CREAM [BARUBT A313 Cosmetic Cream With Retinyl Palmitate]


name: RETINOL 0.018 g in 60 g / GOLD 0.03 g in 60 g / MALTOOLIGOSYL GLUCOSIDE 0.294 g in 60 g CUTANEOUS PASTE [BARUBT 24K GOLD COLLAGEN PEEL-OFF MASK]


name: SAFFLOWER 4 mg in 20 mg / SESAME OIL UNSAPONIFIABLES 3 mg in 20 mg / GINGER OIL 2 mg in 20 mg / ANGELICA ACUTILOBA WHOLE 5 mg in 20 mg TOPICAL OIL [Germinal Oil]


name: SAFFLOWER 4.05 g in 27 g / ANGELICA ACUTILOBA WHOLE 5.4 g in 27 g / GINGER 6.75 g in 27 g TOPICAL PATCH [Bum-Fat Arm Slimming Moxibustion Patch]


name: ARTEMISIA ARGYI LEAF 0.0007 g in 40 g / NIACINAMIDE 0.08 g in 40 g / SALICYLIC ACID 1.28 g in 40 g CUTANEOUS PASTE [BARUBT Mugwort Acne Clay Stick]


name: ARTEMISIA VULGARIS TOP OIL 0.01 g TOPICAL PATCH [Wormwood Belly Button Patch]


name: CAFFEINE 13.25 g in 53 g / EPIGALLOCATECHIN GALLATE 10.6 g in 53 g / CAPSAICIN 7.95 g in 53 g / STYPHNOLOBIUM JAPONICUM WHOLE 5.3 g in 53 g TOPICAL PATCH [Belly Shaping Patch]


name: TOCOPHEROL 2 g in 40 a / BIOTIN 2 g in 40 a / PANTOTHENIC ACID 2 g in 40 a TOPICAL CAPSULE [HAIR GROWTH]


name: TOCOPHEROL 450 mg in 45 mL / ASCORBIC ACID 450 mg in 45 mL / FERMENT COMPLEX 6/PF 18000 mg in 45 mL / COLLAGEN, SOLUBLE, FISH SKIN 900 mg in 45 mL / ASIAN GINSENG 900 mg in 45 mL / GARDEN SNAIL MUCIN 9000 mg in 45 mL TOPICAL LIQUID [AOAO Snail Ginseng Anti Wrinkle Age Essence Box Set]


name: ZINC OXIDE 160 mg in 1 g TOPICAL CREAM [Proceuticals Private Label by TiZO non-tinted replenishing daily protection]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 5 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL SPRAY [Golden Sunglaze Sheer Body Mist Sunscreen SPF50]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / ZINC OXIDE 100 mg in 1 g TOPICAL GEL [Sunscreen]


name: OCTISALATE 50 mg in 1 mL / HOMOSALATE 5 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL SPRAY [Sunglaze Sheer Setting Mist Sunscreen SPF50]


name: ZINC OXIDE 23.8 g in 100 g TOPICAL STICK [Pure Protect Mineral Sunscreen Stick SPF50]


name: ALPHA-ARBUTIN 4 g in 100 mL / TOCOPHEROL 2 g in 100 mL / NIACINAMIDE 2 g in 100 mL / GLUTATHIONE 4 g in 100 mL / NEPIDERMIN 2 g in 100 mL TOPICAL LIQUID [ST.LAWRENCE ANTI-AGING AND WHITENING MASK]


name: ARNICA MONTANA 7 g in 100 mL / HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK 2.5 g in 100 mL TOPICAL GEL [Nekvnro PFERDEBALSAM]


name: CETYL ETHYLHEXANOATE 3 mg in 100 g / GLYCERIN 5 mg in 100 g CUTANEOUS CREAM


name: COCAMIDOPROPYL BETAINE 1.5 mg in 100 g TOPICAL CREAM [Srripo Amino Acid Facial Cleanser]


name: EQUINE COLLAGEN 1 mg in 30 mL CUTANEOUS CREAM


name: MARINE COLLAGEN, SOLUBLE 3 g in 100 mL / TOCOPHEROL 3 g in 100 mL / NIACINAMIDE 2 g in 100 mL / NEPIDERMIN 2 g in 100 mL TOPICAL LIQUID [ST.LAWRENCE POLYPEPTIDE COLLAGEN WHITENING FACIAL MASK]


name: ALUMINUM CHLOROHYDRATE 45 mg in 1 mL TOPICAL LIQUID [ZONSEN Antiperspirant]


name: ALUMINUM CHLOROHYDRATE 78 mg in 1 mL TOPICAL LOTION [ZONSEN Roll-On Antiperspirant]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 1000 mg in 1 mL / OCTISALATE 250 mg in 1 mL / OCTOCRYLENE 360 mg in 1 mL TOPICAL LOTION [Sunscreen]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 1440 mg in 1 mL / OCTISALATE 250 mg in 1 mL / OCTOCRYLENE 1000 mg in 1 mL TOPICAL LOTION [sheer]


name: NIACINAMIDE 10 g in 100 mL TOPICAL LIQUID


name: KOJIC ACID 0.35 g in 100 g / ARBUTIN 1 g in 100 g TOPICAL SOAP [GZE RainbowSoap]


name: AVOBENZONE 25 mg in 1 mL / OCTINOXATE 55 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL LOTION [Tiege Hanley AM Morning Facial Moisturizer with SPF 20]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [Target Up and Up SPF 50 Sunscreen]


name: HYDROXYACETOPHENONE 17.5 mg in 50 g / NIACINAMIDE 10 mg in 50 g / BUTYLENE GLYCOL 150 mg in 50 g / PROPANEDIOL 115 mg in 50 g CUTANEOUS EMULSION [xiufumianshuang]


name: MENTHA ARVENSIS WHOLE 2.44 g in 12.2 g / WHITE PEPPER 3.05 g in 12.2 g / GINGER 1.83 g in 12.2 g / MILK THISTLE 1.22 g in 12.2 g TOPICAL PATCH [SOUTH MOON Bee Venom Slimming Patch]


name: CAFFEINE 75 mg in 15 g / RETINOL 15 mg in 15 g CUTANEOUS EMULSION [Caffeine Cream]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 5.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL AEROSOL, SPRAY [HAWAIIAN TROPIC]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 9 g in 100 mL TOPICAL LOTION [Olay Complete Plus Daily Facial Moisturizer with Sunscreen Broad Spectrum SPF 40]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 2.6 g in 100 mL TOPICAL LOTION [Olay Total Effects Advanced Facial Moisturizer with Sunscreen Broad Spectrum SPF 15 Fragrance-Free]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 150 mg in 1 g / OCTOCRYLENE 100 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL SPRAY [Target Up and Up SPF 70 Sport Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL LOTION [Target Up and Up SPF 30 Sport Sunscreen]


name: ALUMINUM CHLOROHYDRATE 60 mg in 1 mL AURICULAR (OTIC) EMULSION [Antiperspirant]


name: ZINC OXIDE 206 mg in 1 g TOPICAL SPRAY [Target Up and Up SPF 50 Mineral Zinc Oxide Sunscreen]


name: ZINC OXIDE 206 mg in 1 mL TOPICAL LOTION [Target Up and Up SPF 50 Mineral Zinc Oxide Sunscreen]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Target Up and Up SPF 50 Mineral Zinc Oxide Sunscreen Stick]


name: ZINC OXIDE 6.35 g in 50 mL / OCTISALATE 2.25 g in 50 mL / TITANIUM DIOXIDE 1.1 g in 50 mL / HOMOSALATE 3.75 g in 50 mL TOPICAL CREAM [Dr.Oracle AIR FIT DEFENSE SOOTHING SUNSCREEN]


name: GLYCERIN 4 mg in 100 g TOPICAL CREAM [Srripo Turmeric Facial Scrub]


name: HYALURONIC ACID 1 mg in 30 mL CUTANEOUS CREAM


name: ISOPROPYL PALMITATE 3 mg in 200 g / GLYCERIN 5 mg in 200 g CUTANEOUS CREAM


name: KOJIC ACID 3 mg in 30 mg / NIACINAMIDE 1.5 mg in 30 mg / MARINE COLLAGEN, SOLUBLE 1.5 mg in 30 mg / ASCORBIC ACID 4.5 mg in 30 mg TOPICAL LIQUID [JAYSUING 5 In 1 Facial Serum]


name: ASCORBIC ACID 1 mg in 30 mL CUTANEOUS CREAM


name: ASCORBIC ACID 4.5 g in 30 g / PEA 3 g in 30 g / NIACINAMIDE 4.5 g in 30 g / CHAMOMILE 3 g in 30 g TOPICAL CREAM [OUHOE Inner Thighs Bleaching Cream]


name: ASCORBIC ACID 6 g in 30 g / ACETYL HEXAPEPTIDE-8 AMIDE 4.5 g in 30 g / GLYCYRRHIZA URALENSIS ROOT 4.5 g in 30 g / PAEONIA LACTIFLORA ROOT 3 g in 30 g TOPICAL CREAM [OUHOE Retinol Collagen Complex Day Night Cream]


name: ASIAN GINSENG 2600 mg in 130 g / COLLAGEN, SOLUBLE, FISH SKIN 2600 mg in 130 g / TOCOPHEROL 1300 mg in 130 g / ASCORBIC ACID 1300 mg in 130 g / GARDEN SNAIL MUCIN 58500 mg in 130 g TOPICAL CREAM [AOAO SnailI Ginseng Anti Wrinkle Cream]


name: BIOTIN 2 g in 30 mL TOPICAL OIL [Hair Strengthens]


name: CENTELLA ASIATICA TRITERPENOIDS 6 mg in 30 mg / NIACINAMIDE 4.5 mg in 30 mg / ASCORBIC ACID 4.5 mg in 30 mg / GLUTATHIONE 3 mg in 30 mg / CHAMOMILE 3 mg in 30 mg TOPICAL CREAM [JAYSUING Snow Bleach Cream]


name: MAGNESIUM ASCORBYL PHOSPHATE 2 g in 2 g TOPICAL LOTION


name: PROPANEDIOL 5.00195 g in 50 g / GLYCERIN 4.000925 g in 50 g / DIMETHICONE 2.6292 g in 50 g AURICULAR (OTIC) EMULSION


name: PUMPKIN SEED OIL 1 mg in 60 mL CUTANEOUS LIQUID


name: SHEA BUTTER 9 g in 60 g / HYALURONIC ACID 18 g in 60 g / ALOE VERA LEAF 9 g in 60 g / JOJOBA OIL 6 g in 60 g / PHYTONADIONE 6 g in 60 g TOPICAL CREAM [EELHOE Vitamin K Cream]


name: TURMERIC 14.5 g in 58 g / KOJIC ACID 11.6 g in 58 g / CHRYSANTHELLUM INDICUM TOP 8.7 g in 58 g TOPICAL PATCH [EELHOE Kojic Acid Turmeric Cleansing Pads]


name: 1,2-HEXANEDIOL 3 mg in 250 mL / ISOPROPYL PALMITATE 5 mg in 250 mL CUTANEOUS LOTION


name: {1 (acetaminophen 32 MG/ML / dextromethorphan hydrobromide 0.5 MG/ML Oral Suspension) / 1 (acetaminophen 32.5 MG/ML / diphenhydramine hydrochloride 1.25 MG/ML Oral Suspension) } Pack


name: {1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML Oral Suspension) / 1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1.5 MG/ML / doxylamine succinate 0.625 MG/ML Oral Suspension) } Pack


name: Use of Anti-Piracy Technology in CPT Professional 2025 Codebook


name: Synchronous Audio-Video Evaluation and Management Services


name: Synchronous Audio-Video Evaluation and Management Services - New Patient


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with straightforward medical decision making, if using time 15 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and straightforward medical decision making If using time, at least 15 minutes of total time on the encounter date must be met.


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with low medical decision making, if using time 30 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and low medical decision making If using time, at least 30 minutes of total time on the encounter date must be met.


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with moderate medical decision making, if using time 45 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and moderate medical decision making If using time, at least 45 minutes of total time on the encounter date must be met.


name: Synchronous audio-video visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.


name: New patient synchronous audio-video visit with high medical decision making, if using time 60 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and high medical decision making If using time, at least 60 minutes of total time on the encounter date must be met.


name: Synchronous Audio-Video Evaluation and Management Services - Established Patient


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 10 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with straightforward medical decision making, if using time 10 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and straightforward medical decision making If using time, at least 10 minutes of total time on the encounter date must be met.


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with low medical decision making, if using time 20 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and low medical decision making If using time, at least 20 minutes of total time on the encounter date must be met.


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with moderate medical decision making, if using time 30 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and moderate medical decision making If using time, at least 30 minutes of total time on the encounter date must be met.


name: Synchronous audio-video visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high medical decision making. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.


name: Established patient synchronous audio-video visit with high medical decision making, if using time 40 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and high medical decision making If using time, at least 40 minutes of total time on the encounter date must be met.


name: Synchronous Audio-Only Evaluation and Management Services


name: Synchronous Audio-Only Evaluation and Management Services - New Patient


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, straightforward medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with straightforward medical decision making and 10 minutes or more of medical discussion, if using time 15 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and straightforward medical decision making, with more than 10 minutes of medical discussion. If using time, at least 15 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, low medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with low medical decision making and 10 minutes or more of medical discussion, if using time 30 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and low medical decision making, with more than 10 minutes of medical discussion. If using time, at least 30 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, moderate medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with moderate medical decision making and 10 minutes or more of medical discussion, if using time 45 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and moderate medical decision making, with more than 10 minutes of medical discussion. If using time, at least 45 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination, high medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.


name: New patient synchronous audio-only visit with high medical decision making and 10 minutes or more of medical discussion, if using time 60 minutes or more


name: Synchronous audio-only visit for evaluation and management of new patient, including medically appropriate history and high medical decision making, with more than 10 minutes of medical discussion. If using time, at least 60 minutes of total time on the encounter date must be met.


name: Synchronous Audio-Only Evaluation and Management Services - Established Patient


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, straightforward medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 10 minutes must be exceeded.


name: Established patient synchronous audio-only visit with straightforward medical decision making and 10 minutes or more of medical discussion, if using time 10 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and straightforward medical decision making, with more than 10 minutes of medical discussion. If using time, at least 10 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, low medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.


name: Established patient synchronous audio-only visit with low medical decision making and 10 minutes or more of medical discussion, if using time 20 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and low medical decision making, with more than 10 minutes of medical discussion. If using time, at least 20 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, moderate medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.


name: Established patient synchronous audio-only visit with moderate medical decision making and 10 minutes or more of medical discussion, if using time 30 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and moderate medical decision making, with more than 10 minutes of medical discussion. If using time, at least 30 minutes of total time on the encounter date must be met.


name: Synchronous audio-only visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination, high medical decision making, and more than 10 minutes of medical discussion. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.


name: Established patient synchronous audio-only visit with high medical decision making and 10 minutes or more of medical discussion, if using time 40 minutes or more


name: Synchronous audio-only visit for evaluation and management of established patient, including medically appropriate history and high medical decision making, with more than 10 minutes of medical discussion. If using time, at least 40 minutes of total time on the encounter date must be met.


name: Brief Synchronous Communication Technology Service (eg, Virtual Check-In)


name: Established patient brief communication technology-based service with 5-10 minutes of medical discussion


name: Brief communication technology-based service (eg, virtual check-in) by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related evaluation and management service provided within the previous 7 days nor leading to an evaluation and management service or procedure within the next 24 hours or soonest available appointment, 5-10 minutes of medical discussion


name: Initial hospital inpatient or observation care with moderate level of medical decision making. If using time, 55 minutes or more


name: Initial hospital inpatient or observation care with high level of medical decision making, if using time, 75 minutes or more


name: Subsequent hospital inpatient or observation care with high level of medical decision making, if using time, 35 minutes or more


name: Subsequent hospital inpatient or observation care with high level of medical decision making, if using time, 50 minutes or more


name: Hospital inpatient or observation care with admission and discharge on the same date with straightforward or low level of medical decision making, if using time, 45 minutes or more


name: Hospital inpatient or observation care with admission and discharge on the same date with moderate level of medical decision making, if using time, 70 minutes or more


name: Hospital inpatient or observation care with admission and discharge on the same date with high level of medical decision making, if using time, 85 minutes or more


name: Hospital inpatient or observation discharge day management, 30 minutes or less


name: Hospital inpatient or observation discharge day management, more than 30 minutes


name: Office or other outpatient consultation with straightforward medical decision making, if using total time, 20 minutes or more


name: Office or other outpatient consultation with low level of medical decision making, if using time, 30 minutes or more


name: Office or other outpatient consultation with moderate level of medical decision making, if using time, 40 minutes or more


name: Office or other outpatient consultation with high level of medical decision making, if using time, 55 minutes or more


name: Inpatient or observation consultation with straightforward medical decision making, if using time, 35 minutes or more


name: Inpatient or observation consultation with low level of medical decision making, if using total time, 45 minutes or more


name: Inpatient or observation consultation with moderate level of medical decision making, if using time, 60 minutes or more


name: Inpatient or observation consultation with high level of medical decision making, if using time, 80 minutes or more


name: Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month


name: Complex chronic care management services for two or more chronic conditions, each additional 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month


name: Harvest of skin for skin cell suspension autograft


name: Harvest of skin for skin cell suspension autograft; first 25 sq cm or less


name: Harvest of skin for skin cell suspension autograft; each additional 25 sq cm or part thereof (List separately in addition to code for primary procedure)


name: Harvest of skin for skin cell suspension self skin graft, each additional 25 sq cm


name: Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration


name: Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration; first 25 sq cm or less of harvested skin


name: Preparation of skin cell suspension self skin graft, first 25 sq cm or less of harvested skin


name: Preparation of skin cell suspension self skin graft, each additional 25 sq cm or less of harvested skin


name: Preparation of skin cell suspension autograft, requiring enzymatic processing, manual mechanical disaggregation of skin cells, and filtration; each additional 25 sq cm of harvested skin or part thereof (List separately in addition to code for primary procedure)


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs; first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to trunk, arms, legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms, legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, arms, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, legs, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, trunk, arms, legs; each additional 480 sq cm or part thereof (List separately in addition to code for primary procedure)


name: Application of skin cell suspension self skin graft to wound and donor sites to trunk, arms, legs, each additional 480 sq cm


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms,


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to arms, legs, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to legs, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, arms, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing to trunk, legs, each additional 480 sq cm or part thereof


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to face, scalp, eyelids, mouth, neck, ears, eye sockets, genitalia, hands, feet, and/or multiple fingers/toes, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to face, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites to face, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, first 480 sq cm or less


name: Application of skin cell suspension self skin graft to wound and donor sites. including application of primary dressing, to mouth, neck, first 480 sq cm or less


name: Application of skin cell suspension autograft to wound and donor sites, including application of primary dressing, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; each additional 480 sq cm or part thereof (List separately in addition to code for primary procedure)


name: Application of skin cell suspension self skin graft to wound and donor sites to face, scalp, eyelids, mouth, neck, ears, eye sockets, genitalia, hands, feet, and/or multiple fingers/toes, each additional 480 sq cm


name: Application of skin cell suspension self skin graft to wound and donor sites, each additional 480 sq cm or part thereof to hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to face, scalp, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia ,each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, each additional 480 sq cm or part thereof


name: Application of skin cell suspension self skin graft to wound and donor sites, including application of primary dressing, to scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits, each additional 480 sq cm or part thereof


name: Arthroplasty, intercarpal or carpometacarpal joints


name: Replacement of joint between wrist and fingers using tissue


name: Arthroplasty, intercarpal or carpometacarpal joints; suspension, including transfer or transplant of tendon, with interposition, when performed


name: Replacement of joint between wrist and fingers using tendon or stitches


name: Suspension arthroplasty of carpometacarpal joint including transfer or transplant of tendon


name: Suspension arthroplasty of intercarpal joint including transfer or transplant of tendon


name: Percutaneous arthrodesis of sacroiliac joint with insertion of transfixation device using imaging guidance


name: Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for development of genetically modified autologous CAR-T cells, per day


name: Chimeric antigen receptor T-cell (CAR-T) therapy, preparation of blood-derived T lymphocytes for cryopreservation


name: Chimeric antigen receptor T-cell (CAR-T) therapy, preparation of blood-derived T lymphocytes for storage


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s)


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 5 cm or less


name: Removal or destruction of growth(s) in the abdomen, 5.0 cm or less


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5 cm or less


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5 cm or less


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5 cm or less


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 5.1 to 10 cm


name: Removal or destruction of growth(s) in the abdomen, 5.1 to 10.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 5.1 to 10 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 5.1 to 10 cm


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 10.1 to 20 cm


name: Removal or destruction of growth(s) in the abdomen, 10.1 to 20.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 10.1 to 20 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 10.1 to 20 cm


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); 20.1 to 30 cm


name: Removal or destruction of growth(s) in the abdomen, 20.1 to 30.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, 20.1 to 30 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, 20.1 to 30 cm


name: Excision or destruction, open, intra-abdominal (ie, peritoneal, mesenteric, retroperitoneal), primary or secondary tumor(s) or cyst(s), sum of the maximum length of tumor(s) or cyst(s); greater than 30 cm


name: Removal or destruction of growth(s) in the abdomen, more than 30.0 cm


name: Open destruction of mesenteric primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of mesenteric primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of mesenteric secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of mesenteric secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of peritoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of peritoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of peritoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of peritoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of retroperitoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of retroperitoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open destruction of retroperitoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open destruction of retroperitoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of mesenteric primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of mesenteric primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of mesenteric secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of mesenteric secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of peritoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of peritoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of peritoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of peritoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of retroperitoneal primary cyst, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of retroperitoneal primary tumor, sum of the maximum length of the tumor, greater than 30 cm


name: Open excision of retroperitoneal secondary cyst, sum of the maximum length of the cyst, greater than 30 cm


name: Open excision of retroperitoneal secondary tumor, sum of the maximum length of the cyst, greater than 30 cm


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation, including suprapubic tube placement during the same session and placement of an endorectal cooling device, when performed


name: Insertion of transducer through urethra for delivery of heat ultrasound for destruction of prostate tissue


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation with suprapubic tube placement


name: Insertion of transurethral ablation transducer for delivery of thermal ultrasound for prostate tissue ablation with suprapubic tube placement and placement of an endorectal cooling device


name: Cystourethroscopy with insertion of temporary device for ischemic remodeling (ie, pressure necrosis) of bladder neck and prostate


name: Insertion of a temporary device for pressure necrosis of bladder neck and prostate using an endoscope